Please login to the form below
3
Revenue 2017Roche
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.
Targacept picks Solvay's Stephen Hill to fill vacant CEO post
Prior to that, he served at US biotech ArQule and Roche, where he held several leadership positions including global head of clinical development.
EC approves Roche’s Tecentriq for early-stage lung cancer
Roche’s Tecentriq (atezolizumab) has been approved by the European Commission (EC) for adults with non-small cell lung cancer (NSCLC) who have a high risk of the disease reoccurring. ... Today’s approval represents an important advance, as Tecentriq
Finalists 2022
for Novartis UK. LADBible Heamophilia. by Hanover Communications. for ROCHE. My MS Space. ... for Roche. Bones in Homes: Opening up Osteoporosis to a Locked Down Audience.
Roche’s Polivy receives EC approval for lymphoma therapy
Following a wait of 20 years for a clinically meaningful improvement for patients with untreated diffuse large B-cell lymphoma (DLBCL), the European Commission (EC) has granted approval of Roche’s ... After more than 20 years with very limited
UICC launches global ATOM Coalition to increase access to essential cancer medicines
Teresa Graham, head of global product strategy, Roche Pharma, said: “Improving global access to quality cancer care is a core commitment at Roche.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Happify Health and Almirall launch Claro to support psoriasis patients
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Bristol Myers Squibb announces positive trial results for treatment of MS
- ‘The man behind the mouse’: bringing courage to creativity in healthcare communications
- My journey advancing the science in pulmonary hypertension
- Learning and development: the secret weapon for a successful life science launch
- VMLY&R wins two Grand Prix awards at Cannes Lions International Festival of Creativity 2022
- EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases
- Novartis announces promising five-year data for leukaemia treatment Kymriah
- A creative awakening – how pharma is bringing innovation to the patient journey
- FDA grants Pfizer/BioNTech’s COVID-19 vaccine emergency use authorisation for infants
- New virtual health and care report from WHO and Novartis calls for ‘critical action’
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- Learning and development: the secret weapon for a successful life science launch
- Dave Stuteville, Executive Vice President, Learning & Development, reveals the principles behind successfully training Sales Representatives and Medical Science Liaisons for a rapid biopharmaceutical product launch....
- A creative awakening – how pharma is bringing innovation to the patient journey
- By Danny Buckland...
- MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation
- ...
